Goldman Sachs Group Inc Igm Biosciences, Inc. Transaction History

Goldman Sachs Group Inc

$596 Billion
Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 793,386 shares of IGMS stock, worth $983,798. This represents 0.0% of its overall portfolio holdings.

Number of Shares

793,386

Previous 793,386 -0.0%

Holding current value

$983,798

Previous $912,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$1.15 - $6.8 $212,863 - $1.26 Million	-185,099 Reduced 18.92%	793,386 $912,000
Q4 2024 Feb 11, 2025	SELL	$6.05 - $17.83 $1.7 Million - $5.01 Million	-280,745 Reduced 22.29%	978,485 $5.98 Million
Q3 2024 Nov 14, 2024	SELL	$6.28 - $17.68 $469,009 - $1.32 Million	-74,683 Reduced 5.6%	1,259,230 $20.8 Million
Q2 2024 Aug 13, 2024	BUY	$6.51 - $11.47 $359,963 - $634,222	55,294 Added 4.32%	1,333,913 $9.16 Million
Q1 2024 May 15, 2024	BUY	$8.68 - $17.36 $2.07 Million - $4.13 Million	238,110 Added 22.88%	1,278,619 $12.3 Million
Q4 2023 Feb 13, 2024	BUY	$3.94 - $8.79 $2.3 Million - $5.13 Million	583,516 Added 127.69%	1,040,509 $8.65 Million
Q3 2023 May 14, 2024	SELL	$6.66 - $10.64 $3.89 Million - $6.21 Million	-583,516 Reduced 56.08%	456,993 $3.82 Million
Q3 2023 Nov 14, 2023	SELL	$6.66 - $10.64 $1.43 Million - $2.29 Million	-215,196 Reduced 32.01%	456,993 $3.82 Million
Q2 2023 May 14, 2024	BUY	$8.86 - $14.0 $2.47 Million - $3.9 Million	278,675 Added 70.82%	672,189 $6.2 Million
Q2 2023 Aug 14, 2023	BUY	$8.86 - $14.0 $2.47 Million - $3.9 Million	278,675 Added 70.82%	672,189 $6.2 Million
Q1 2023 May 14, 2024	BUY	$13.74 - $25.76 $2.67 Million - $5.01 Million	194,588 Added 97.82%	393,514 $5.41 Million
Q1 2023 May 11, 2023	BUY	$13.74 - $25.76 $2.67 Million - $5.01 Million	194,588 Added 97.82%	393,514 $5.41 Million
Q4 2022 May 14, 2024	SELL	$15.45 - $26.02 $777,799 - $1.31 Million	-50,343 Reduced 20.2%	198,926 $3.38 Million
Q4 2022 Feb 13, 2023	SELL	$15.45 - $26.02 $777,799 - $1.31 Million	-50,343 Reduced 20.2%	198,926 $3.38 Million
Q3 2022 May 14, 2024	BUY	$15.42 - $27.01 $782,025 - $1.37 Million	50,715 Added 25.54%	249,269 $5.67 Million
Q3 2022 Nov 10, 2022	BUY	$15.42 - $27.01 $782,025 - $1.37 Million	50,715 Added 25.54%	249,269 $5.67 Million
Q2 2022 May 14, 2024	SELL	$13.27 - $25.5 $11.2 Million - $21.5 Million	-841,955 Reduced 80.92%	198,554 $3.58 Million
Q2 2022 Aug 15, 2022	SELL	$13.27 - $25.5 $3.05 Million - $5.85 Million	-229,533 Reduced 53.62%	198,554 $3.58 Million
Q1 2022 May 16, 2022	BUY	$13.42 - $29.73 $328,293 - $727,284	24,463 Added 6.06%	428,087 $11.4 Million
Q4 2021 Feb 14, 2022	SELL	$27.59 - $66.39 $78,797 - $189,609	-2,856 Reduced 0.7%	403,624 $11.8 Million
Q3 2021 Nov 10, 2021	BUY	$65.76 - $90.65 $26.7 Million - $36.8 Million	406,480 New	406,480 $26.7 Million

Others Institutions Holding IGMS

# of Institutions

Shares Held

16.2M

Call Options Held

26.8K

Put Options Held

800

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $35.9M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Igm Biosciences, Inc. Transaction History